Type of immune cells | Thirty patients with the initial DCIS before recurrence (%) | Thirty patients after detection of invasive recurrence (%) | Eleven patients without recurrence (%) |
---|---|---|---|
CD20+ | 30/30 (100) | 30/30 (100) | 11/11 (100) |
CD163+ | 22/30 (73) | 26/30 (87) | 8/11 (73) |
CD138+ | 26/30 (87) | 30/30 (100) | 5/11 (45) |
CD4+ | 19/30 (63) | 23/30 (77) | 5/11 (45) |
CD8+ | 30/30 (100) | 27/30 (90) | 11/11 (100) |
FOXP3+ | 11/30 (37) | 20/30 (67) | 5/11 (45) |
TGF-beta | 9/30 (30) | 24/30 (80) | 2/11 (18) |